Last update Dec. 30, 2021
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
R06AE09 is Levocetirizine in ATC Code/s.Is written in other languages:
R06AE09 is also known as
R06AE09 belongs to this group or family:
Main tradenames from several countries containing R06AE09 in its composition:
|T½||8 - 12||hours|
Write us at firstname.lastname@example.org
e-lactancia is a resource recommended by Asociación Pro Lactancia Materna (APROLAM) of Mexico
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM
Second generation antihistamine, derived from piperazine, with minimal sedative effects and very low toxicity even at high doses.
Since the last update we have not found published data on its excretion in breast milk, but it is an enantiomer and active metabolite of cetirizine, that It is excreted in breast milk in clinically insignificant amounts (Wilkerson 2021). No problems were detected in the short or long term in an infant whose mother took cetirizine during the first month after delivery as part of the treatment for pemphigus.(Westermann 2012)
Its high binding to plasma proteins makes its transfer to milk unlikely.
The British Society for Allergy and Clinical Immunology considers cetirizine safe during breastfeeding. (Powell 2007)
See below the information of this related product: